Intrexon | XON - Bruttoergebnis Vom Umsatz





Bruttoergebnis Vom Umsatz Veränderung Datum
Agenus USD 33.74M 468K 2026-03
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 5.87B 1.02B 2026-03
Anika Therapeutics USD 19.18M 3.6M 2025-12
Arrowhead Research USD 75.25M 1.52M 2026-06
AstraZeneca USD 12.86B 251M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Gilead Sciences USD 6.8B 1.29B 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
Heron Therapeutics USD 29.47M 3.17M 2025-12
Incyte USD 1.57B 400.89M 2026-06
Intrexon USD -297K 167K 2024-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Ligand Pharmaceuticals USD 100.41M 51.96M 2026-06
MacroGenics USD 11.24M 19.87M 2026-03
MannKind USD 7.77M 60.56M 2026-06
Merck USD 12.09B 1.24B 2026-03
Novartis USD 11.24B 1.18B 2026-06
Rigel Pharmaceuticals USD 28.49M 7.01M 2024-06
Roche Holding CHF 22.69B 600M 2026-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Veracyte USD 108.55M 7.39M 2026-06
Xencor USD 51.22M 46.7M 2026-06